IBSA is a privately-owned pharmaceutical company, founded in Lugano in 1945. Thanks to a consolidated expansion strategy, IBSA is present with its products in 5 continents and in over 80 countries, including China and the United States. 
Overall, the Group employs 2,000 people, spread among the various offices and production sites of its 13 branches in Europe, China and the United States, while 116 people work in the 14 Research and Development laboratories. 
The IBSA Group currently holds 65 registered patents, and others are currently being developed.
IBSA is currently the largest private capital pharmaceutical company in Switzerland, the fourth largest operator in the fertility area, after the major multinationals, and one of the world leaders in hyaluronic acid-based products.
With regard to production capacity, IBSA can boast some significant figures: 14 million hormone ampoules, 300 million soft capsules and 60 million packages of finished products leave its production sites each year.
The IBSA Group is present with its products in 10 different therapeutic areas: Human reproduction, Rheumatology, Pain and Inflammation, Endocrinology, Dermo Aesthetic, Dermatology, Respiratory, Urology, Cardiovascular and Consumer Health.

Related Categories

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America